{"id":"https://openalex.org/W2886547751","doi":"https://doi.org/10.1007/s40263-018-0554-0","title":"Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain","display_name":"Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain","alternate_titles":[],"publication_year":2018,"publication_date":"2018-08-03","ids":{"openalex":"https://openalex.org/W2886547751","doi":"https://doi.org/10.1007/s40263-018-0554-0","mag":"2886547751","pmid":"https://pubmed.ncbi.nlm.nih.gov/30076539","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6153967"},"language":"en","primary_location":{"id":"doi:10.1007/s40263-018-0554-0","doi":"https://doi.org/10.1007/s40263-018-0554-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40263-018-0554-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40263-018-0554-0.pdf","source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2886547751"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40263-018-0554-0.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"John A. Hey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"John A. Hey","raw_affiliation_strings":["Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA. john.hey@alzheon.com","Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA. john.hey@alzheon.com","institution_ids":[]},{"raw_affiliation_string":"Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088598237","display_name":"Petr Ko\u010di\u0161","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Petr Kocis","raw_affiliation_strings":["Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080845172","display_name":"Jakub Hort","orcid":"https://orcid.org/0000-0002-1080-3726","observed_orcids":["https://orcid.org/0000-0002-1080-3726"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210097985","display_name":"University Hospital in Motol","ror":"https://ror.org/0125yxn03","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210097985","https://openalex.org/I4405269046"]},{"id":"https://openalex.org/I4210114565","display_name":"International Clinical Research Center, St. Anne's University Hospital Brno","ror":"https://ror.org/027v97282","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I4210114565","https://openalex.org/I4210136987"]},{"id":"https://openalex.org/I4210136987","display_name":"St. Anne's University Hospital Brno","ror":"https://ror.org/049bjee35","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210136987"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jakub Hort","raw_affiliation_strings":["Department of Neurology, Cognitive Center, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic","International Clinical Research Centre, St. Anne's University Hospital Brno, Brno, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Cognitive Center, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210097985"]},{"raw_affiliation_string":"International Clinical Research Centre, St. Anne's University Hospital Brno, Brno, Czech Republic","institution_ids":["https://openalex.org/I4210114565","https://openalex.org/I4210136987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113687686","display_name":"Susan R. Abushakra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susan Abushakra","raw_affiliation_strings":["Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110571932","display_name":"Aidan Power","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aidan Power","raw_affiliation_strings":["Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064895122","display_name":"Martin Vyhn\u00e1lek","orcid":"https://orcid.org/0000-0002-5976-4932","observed_orcids":["https://orcid.org/0000-0002-5976-4932"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210097985","display_name":"University Hospital in Motol","ror":"https://ror.org/0125yxn03","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210097985","https://openalex.org/I4405269046"]},{"id":"https://openalex.org/I4210114565","display_name":"International Clinical Research Center, St. Anne's University Hospital Brno","ror":"https://ror.org/027v97282","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I4210114565","https://openalex.org/I4210136987"]},{"id":"https://openalex.org/I4210136987","display_name":"St. Anne's University Hospital Brno","ror":"https://ror.org/049bjee35","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210136987"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Vyhn\u00e1lek","raw_affiliation_strings":["Department of Neurology, Cognitive Center, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic","International Clinical Research Centre, St. Anne's University Hospital Brno, Brno, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Cognitive Center, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210097985"]},{"raw_affiliation_string":"International Clinical Research Centre, St. Anne's University Hospital Brno, Brno, Czech Republic","institution_ids":["https://openalex.org/I4210114565","https://openalex.org/I4210136987"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045136242","display_name":"Yongxin Yu","orcid":"https://orcid.org/0000-0002-2491-4806","observed_orcids":["https://orcid.org/0000-0002-2491-4806"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeremy Y. Yu","raw_affiliation_strings":["Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078511740","display_name":"Martin Tolar","orcid":"https://orcid.org/0000-0002-3910-091X","observed_orcids":["https://orcid.org/0000-0002-3910-091X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Tolar","raw_affiliation_strings":["Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheon, Inc, 111 Speen Street Suite 306, Framingham, MA, 01701, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5090,"currency":"USD","value_usd":5090},"apc_paid":{"value":5090,"currency":"USD","value_usd":5090},"fwci":1.4214,"has_fulltext":true,"cited_by_count":81,"citation_normalized_percentile":{"value":0.78280631,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"32","issue":"9","first_page":"849","last_page":"861"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tramiprosate","display_name":"tramiprosate","score":0.8899999856948853},{"id":"https://openalex.org/keywords/amyloid-beta-1-42","display_name":"amyloid-beta 42","score":0.7580000162124634},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9860000014305115},{"id":"https://openalex.org/keywords/cerebrospinal-fluid","display_name":"cerebrospinal fluid","score":0.9539999961853027},{"id":"https://openalex.org/keywords/brain-penetration","display_name":"brain penetration","score":0.7319999933242798},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.984000027179718},{"id":"https://openalex.org/keywords/prodrug-metabolism","display_name":"prodrug metabolism","score":0.6679999828338623},{"id":"https://openalex.org/keywords/anti-amyloid-activity","display_name":"anti-amyloid activity","score":0.6970000267028809},{"id":"https://openalex.org/keywords/ion-mobility-mass-spectrometry","display_name":"ion mobility mass spectrometry","score":0.7160000205039978},{"id":"https://openalex.org/keywords/molecular-dynamics","display_name":"molecular dynamics","score":0.5960000157356262},{"id":"https://openalex.org/keywords/drug-naive-patients","display_name":"drug-naive patients","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6552892327308655},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6051574945449829},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.562495231628418},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5416967272758484},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.4964190125465393},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3432316780090332},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.342786580324173},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22714722156524658}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002853","descriptor_name":"Chromatography, Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004333","descriptor_name":"Drug Administration Routes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008609","descriptor_name":"Mental Status Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008956","descriptor_name":"Models, Chemical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011422","descriptor_name":"Propionates","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D013654","descriptor_name":"Taurine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013654","descriptor_name":"Taurine","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D013654","descriptor_name":"Taurine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013654","descriptor_name":"Taurine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017711","descriptor_name":"Nonlinear Dynamics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053719","descriptor_name":"Tandem Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s40263-018-0554-0","doi":"https://doi.org/10.1007/s40263-018-0554-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40263-018-0554-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40263-018-0554-0.pdf","source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5116532","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6153967","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6153967","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6153967/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"Text"},{"id":"pmid:30076539","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30076539","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS drugs","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1007/s40263-018-0554-0","doi":"https://doi.org/10.1007/s40263-018-0554-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40263-018-0554-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40263-018-0554-0.pdf","source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2886547751.pdf","grobid_xml":"https://content.openalex.org/works/W2886547751.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W568970981","https://openalex.org/W1588464112","https://openalex.org/W1613370405","https://openalex.org/W1637989849","https://openalex.org/W1966895399","https://openalex.org/W1969697451","https://openalex.org/W2008301592","https://openalex.org/W2029918421","https://openalex.org/W2032044839","https://openalex.org/W2032061707","https://openalex.org/W2042492049","https://openalex.org/W2055775253","https://openalex.org/W2062642061","https://openalex.org/W2063236931","https://openalex.org/W2063808031","https://openalex.org/W2095212600","https://openalex.org/W2112957305","https://openalex.org/W2123681603","https://openalex.org/W2141318707","https://openalex.org/W2165021720","https://openalex.org/W2409474747","https://openalex.org/W2510806376","https://openalex.org/W2526756851","https://openalex.org/W2564454435","https://openalex.org/W2606668492","https://openalex.org/W2765415508","https://openalex.org/W2808356172","https://openalex.org/W2901927471","https://openalex.org/W2913278535","https://openalex.org/W2987479240","https://openalex.org/W4211050998"],"related_works":["https://openalex.org/W2981083993","https://openalex.org/W2766989805","https://openalex.org/W2766028168","https://openalex.org/W2308545022","https://openalex.org/W2533052742","https://openalex.org/W4407175171","https://openalex.org/W4399853387","https://openalex.org/W2606668492","https://openalex.org/W2750337805","https://openalex.org/W2032061707"],"abstract_inverted_index":{"BACKGROUND:":[0],"ALZ-801":[1,20,448],"is":[2,21,51,337,473],"an":[3,52,474],"oral,":[4],"small-molecule":[5],"inhibitor":[6],"of":[7,24,42,66,78,89,105,110,130,140,194,212,243,250,255,270,291,300,306,310,351,356,361,374,380,410,420,438,447,460,484,495,511,524,543,546,552,559],"beta":[8],"amyloid":[9],"(A\u03b2)":[10],"oligomer":[11,128,406],"formation":[12,494],"in":[13,55,61,91,107,125,172,252,272,320,358,387,394,430,440,488,500,508,516,529,535,549,561,570],"clinical":[14,34],"development":[15],"for":[16],"Alzheimer's":[17],"disease":[18],"(AD).":[19],"a":[22,198,288,372],"prodrug":[23,46],"tramiprosate":[25,43,115,167,278,311,392,450,530],"with":[26,68,98,112,150,163,166,197,206,214,258,274,277,293,314,365,389,415,477,518],"improved":[27],"pharmacokinetic":[28,238],"properties":[29,139,239],"and":[30,44,59,70,85,132,137,160,202,217,228,240,312,329,340,371,427,493,572],"gastrointestinal":[31],"tolerability.":[32],"During":[33],"studies,":[35,323],"we":[36,399],"discovered":[37],"that":[38,296,334,401,419,433,471],"the":[39,56,62,87,103,108,124,135,173,190,218,237,248,253,298,307,335,342,348,353,359,434,441,458,461,464,481,504,509,521,525,540,547,550],"primary":[40],"metabolite":[41,336,355,462,548],"its":[45,567],"ALZ-801,":[47],"3-sulfopropanoic":[48],"acid":[49],"(3-SPA),":[50],"endogenous":[53,195,349,475],"molecule":[54],"human":[57,442],"brain":[58,73,241,331,428,443],"present":[60],"cerebrospinal":[63],"fluid":[64],"(CSF)":[65],"patients":[67,97,111,149,162,257,273,364,388,517],"AD":[69,113,164,275,370,390,519,562,571],"other":[71,375,573],"neurodegenerative":[72,376,574],"diseases.":[74],"OBJECTIVE:":[75],"The":[76,267,378,555],"objectives":[77],"this":[79],"research":[80],"were":[81,180,233,382],"to":[82,188,209,235,369,384,418,454],"(1)":[83],"identify":[84],"confirm":[86,189],"presence":[88,249,350],"3-SPA":[90,106,196,199,213,251,271,292,313,324,381,402,422,439,472,560],"CSF":[92,109,144,254,360,436],"samples":[93,145],"from":[94,114,146,457],"elderly,":[95],"drug-na\u00efve":[96,148,256,362,395],"memory":[99,366],"deficits;":[100],"(2)":[101],"quantify":[102],"levels":[104,379,545],"phase":[116,174,531],"III":[117,175,532],"North":[118],"American":[119],"(NA)":[120],"trial;":[121],"(3)":[122],"evaluate":[123],"vitro":[126,285],"anti-A\u03b242":[127],"activity":[129,479],"3-SPA;":[131],"(4)":[133],"characterize":[134,210,236],"pharmacokinetics":[136],"brain-penetration":[138],"3-SPA.":[141,244],"METHODS:":[142],"Lumbar":[143],"64":[147],"cognitive":[151,259],"deficits":[152,260,367],"(Mini-Mental":[153],"State":[154],"Examination":[155],"[MMSE]":[156],"score":[157],"range":[158],"15-30)":[159],"six":[161],"treated":[165,276],"150":[168],"mg":[169],"twice":[170],"daily":[171],"trial,":[176],"at":[177],"week":[178],"78,":[179],"analyzed.":[181],"We":[182,246,346],"used":[183],"liquid":[184],"chromatography-tandem":[185],"mass":[186],"spectrometry":[187,205],"structural":[191],"molecular":[192,207,308],"identity":[193],"reference":[200],"standard":[201],"ion-mobility":[203],"spectrometry-mass":[204],"dynamics":[208],"interactions":[211,309],"A\u03b242":[215,295,301,315,411],"monomers,":[216],"resultant":[219],"conformational":[220,482],"alterations.":[221],"Rat":[222],"studies":[223,286,533],"using":[224],"oral":[225,327,425,445],"(30":[226],"mg/kg)":[227,231],"intravenous":[229],"(10":[230],"doses":[232],"conducted":[234],"penetration":[242,429,459],"RESULTS:":[245],"confirmed":[247,347],"(mean":[261],"concentration":[262,269],"11.7":[263],"\u00b1":[264,281],"4.3":[265],"nM).":[266],"mean":[268],"was":[279],"135":[280],"51":[282],"nM.":[283],"In":[284,397],"revealed":[287],"multi-ligand":[289],"interaction":[290],"monomeric":[294],"inhibits":[297],"aggregation":[299,409],"into":[302,412,463],"small":[303,413],"oligomers.":[304],"Comparisons":[305],"are":[316],"also":[317],"presented.":[318],"Furthermore,":[319],"rat":[321],"preclinical":[322],"displayed":[325],"100%":[326],"bioavailability":[328],"25%":[330],"penetration,":[332],"indicating":[333],"well":[338,565],"absorbed":[339],"crosses":[341],"blood-brain":[343],"barrier.":[344],"CONCLUSIONS:":[345],"3-SPA,":[352],"major":[354],"tramiprosate,":[357],"elderly":[363],"due":[368],"variety":[373],"disorders.":[377],"up":[383],"12.6-fold":[385],"greater":[386],"receiving":[391],"than":[393],"patients.":[396,554],"addition,":[398],"showed":[400],"has":[403],"potent":[404],"anti-A\u03b2":[405],"activity,":[407],"inhibiting":[408],"oligomers":[414,499],"efficacy":[416],"comparable":[417],"tramiprosate.":[421],"displays":[423],"excellent":[424],"availability":[426],"rats,":[431],"suggesting":[432],"higher":[435],"concentrations":[437],"after":[444],"administration":[446],"or":[449],"(and":[451],"subsequent":[452],"conversion":[453],"3-SPA)":[455],"result":[456],"central":[465],"nervous":[466],"system.":[467],"These":[468],"data":[469],"suggest":[470],"agent":[476],"potential":[478,556],"stabilizing":[480],"flexibility":[483],"A\u03b2":[485,491,498],"monomers":[486],"that,":[487],"turn,":[489],"inhibit":[490],"misfolding":[492],"soluble":[496],"toxic":[497],"humans,":[501],"thereby":[502],"preventing":[503],"initial":[505],"pathogenic":[506],"step":[507],"progression":[510],"AD.":[512],"Clinical":[513],"improvements":[514],"observed":[515],"carrying":[520],"\u03b54":[522],"allele":[523],"apolipoprotein":[526],"E":[527],"gene":[528],"may":[534],"part":[536],"be":[537],"explained":[538],"by":[539],"therapeutic":[541,568],"effects":[542],"excess":[544],"brains":[551],"these":[553],"protective":[557],"role":[558,569],"pathogenesis,":[563],"as":[564,566],"disorders,":[575],"warrants":[576],"further":[577],"investigation.":[578]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2886547751","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-08-22T00:00:00"}
